GlaxoSmithKline plc (GSK) Insider Victoria Whyte Buys 8 Shares of Stock
GlaxoSmithKline plc (LON:GSK) insider Victoria Whyte acquired 8 shares of the company’s stock in a transaction that occurred on Wednesday, November 9th. The stock was acquired at an average price of GBX 1,593 ($19.73) per share, with a total value of £127.44 ($157.86).
Shares of GlaxoSmithKline plc (LON:GSK) opened at 1573.50 on Friday. The firm’s market capitalization is GBX 76.57 billion. GlaxoSmithKline plc has a 1-year low of GBX 1,277.25 and a 1-year high of GBX 1,745.56. The firm’s 50 day moving average is GBX 1,642.88 and its 200 day moving average is GBX 1,582.95.
The business also recently announced a dividend, which will be paid on Thursday, January 12th. Shareholders of record on Thursday, November 3rd will be paid a GBX 19 ($0.24) dividend. This represents a yield of 1.17%. The ex-dividend date is Thursday, November 3rd.
Several research firms have commented on GSK. Credit Suisse Group AG reiterated a “neutral” rating and set a GBX 1,800 ($22.30) price target on shares of GlaxoSmithKline plc in a report on Thursday, July 14th. S&P Global Inc. set a GBX 1,650 ($20.44) price target on shares of GlaxoSmithKline plc and gave the stock a “neutral” rating in a report on Wednesday, July 27th. BNP Paribas reiterated a “neutral” rating on shares of GlaxoSmithKline plc in a report on Friday, July 29th. Goldman Sachs Group Inc. reiterated a “buy” rating and set a GBX 1,800 ($22.30) price target on shares of GlaxoSmithKline plc in a report on Thursday, October 27th. Finally, Citigroup Inc. set a GBX 1,800 ($22.30) price target on shares of GlaxoSmithKline plc and gave the stock a “buy” rating in a report on Thursday, September 29th. Two equities research analysts have rated the stock with a sell rating, fifteen have issued a hold rating and nine have assigned a buy rating to the company. The stock has an average rating of “Hold” and a consensus price target of GBX 1,723.54 ($21.35).
About GlaxoSmithKline plc
GlaxoSmithKline plc (GSK) is a healthcare company. The Company is engaged in the creation and discovery, development, manufacture and marketing of pharmaceutical products, including vaccines, over-the-counter (OTC) medicines and health-related consumer products. The Company’s segments include Pharmaceuticals, Pharmaceuticals R&D, Vaccines and Consumer Healthcare.
Receive News & Stock Ratings for GlaxoSmithKline plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GlaxoSmithKline plc and related stocks with our FREE daily email newsletter.